MARKET

IBO

IBO

Impact Biomedical, Inc.
AMEX
2.150
+0.030
+1.42%
Closed 16:00 12/12 EST
OPEN
2.160
PREV CLOSE
2.120
HIGH
2.450
LOW
2.130
VOLUME
12.51K
TURNOVER
--
52 WEEK HIGH
3.250
52 WEEK LOW
1.220
MARKET CAP
24.72M
P/E (TTM)
-10.2674
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IBO last week (1202-1206)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 12/02 21:05
Weekly Report: what happened at IBO last week (1125-1129)?
Weekly Report · 12/02 12:50
Weekly Report: what happened at IBO last week (1118-1122)?
Weekly Report · 11/25 12:36
Impact BioMedical CEO says ‘well-positioned’ to drive long-term value
TipRanks · 11/19 13:10
Weekly Report: what happened at IBO last week (1111-1115)?
Weekly Report · 11/18 12:32
Based on the provided financial report articles, I generated the title for the article: "IMPB Reports Q3 2024 Financial Results: Strong Revenue Growth and Earnings" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred the title to be related to the company's financial results for the third quarter of 2024.
Press release · 11/13 06:36
Weekly Report: what happened at IBO last week (1104-1108)?
Weekly Report · 11/11 12:54
More
About IBO
Impact Biomedical Inc. is a human healthcare company and is a wholly owned subsidiary of DSS, Inc. The Company, through the utilization of its intellectual property rights, or through investment in, or through acquisition of companies in the bio health and biomedical fields, focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The Company, through its subsidiary, Global BioLife, Inc., focuses on research in four main areas: the Linebacker project, which develops a universal therapeutic drug platform; a new sugar substitute called Laetose; a multi-use fragrance called 3F (Functional Fragrance Formulation), which is a mosquito fragrance product; and Equivir/Nemovir, a blend of natural polyphenols designed as an antimicrobial medication.

Webull offers Impact Biomedical Inc stock information, including AMEX: IBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IBO stock methods without spending real money on the virtual paper trading platform.